Original Research
Published on 09 Jul 2018
Immune Cell Profiling During Switching from Natalizumab to Fingolimod Reveals Differential Effects on Systemic Immune-Regulatory Networks and on Trafficking of Non-T Cell Populations into the Cerebrospinal Fluid—Results from the ToFingo Successor Study
in Multiple Sclerosis and Neuroimmunology
- Lisa Lohmann
- Claudia Janoschka
- Andreas Schulte-Mecklenbeck
- Svenja Klinsing
- Lucienne Kirstein
- Uta Hanning
- Timo Wirth
- Tilman Schneider-Hohendorf
- Nicholas Schwab
- Catharina C. Gross
Frontiers in Immunology
doi 10.3389/fimmu.2018.01560